Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
231 hedge funds and large institutions have $2.38B invested in Cantel Medical Corporation in 2016 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 90 increasing their positions, 72 reducing their positions, and 18 closing their positions.
89% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 18
25% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 72
6% more funds holding
Funds holding: 218 → 231 (+13)
3% less capital invested
Capital invested by funds: $2.46B → $2.38B (-$82.4M)
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$15.9M |
| 2 |
RCM
Riverhead Capital Management
Wilmington,
Delaware
|
+$12.9M |
| 3 |
Neuberger Berman Group
New York
|
+$12.4M |
| 4 |
Morgan Stanley
New York
|
+$12M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$9.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
-$62M |
| 2 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$16.1M |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
-$15.8M |
| 4 |
NAM
Nichols Asset Management
Sudbury,
Massachusetts
|
-$10.8M |
| 5 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$8.47M |
CMD Hedge Fund Activity: Q2 2016 in Review
231 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q2 2016, worth a combined $2.38B — down 3.3% from $2.46B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new CMD positions and 18 closed out — a net gain of 16 holders — while 90 added to existing stakes and 72 trimmed.
The largest buyer was Janus Henderson Group, adding an estimated $15.9M. The largest seller was EARNEST Partners, cutting an estimated $62M.
- 231 institutional investors held Cantel Medical Corporation (CMD) as of Q2 2016, up from 218 in Q1 2016.
- Funds reported $2.38B of Cantel Medical Corporation stock for Q2 2016, down 3.3% quarter-over-quarter.
- 34 funds opened new Cantel Medical Corporation positions in Q2 2016 and 18 closed out, a net change of +16 holders.
- The largest Cantel Medical Corporation buyer in Q2 2016 was Janus Henderson Group, an estimated $15.9M added.
- The largest Cantel Medical Corporation seller in Q2 2016 was EARNEST Partners, an estimated $62M sold.
Based on aggregated 13F filings for Q2 2016.